Buffered lidocaine for myofascial pain: a comparison with lidocaine alone
Official title: Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome Using Surface Electromyography (sEMG)
Run by Cairo University · NCT07572994 · Data updated 2026-11-12
This study tests whether adding sodium bicarbonate to lidocaine can improve pain relief for people with myofascial pain syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 70 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo, Cairo Governorate) |
| Status | Recruiting |
| Started | November 1, 2026 |
| Main results expected | April 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07572994 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Candidates are adults 16–70 with diagnosed myofascial pain syndrome and active trigger points who have not had a trigger point injection in the past 3 months and can consent to participation.
✕Probably not a fit
Patients unlikely to benefit include those with lidocaine or bicarbonate allergies, those with active infections at the injection site, or those with exclusionary conditions such as fibromyalgia or major psychiatric disorders.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, parallel-group, single-blind trial compares lidocaine alone to lidocaine buffered with sodium bicarbonate for trigger point injections in myofascial pain syndrome. Outcome measures include pain scores and functional assessments, with surface electromyography used to characterize muscle activity. Eligible participants are aged 16 to 70 with documented MPS and active trigger points, and follow-up visits monitor safety and response to treatment. The study aims to see if buffering lidocaine provides faster onset, less injection pain, and longer-lasting relief than lidocaine alone. Lead sponsorship is Cairo University, conducted at the Faculty of Dentistry in Cairo, with no listed collaborators.
Why it matters
Potential benefit: If successful, patients may experience faster onset and longer-lasting pain relief from trigger point injections with buffered lidocaine.
How similar studies have gone: Past research suggests buffering lidocaine can reduce injection pain and may speed onset, but evidence in myofascial pain management remains limited, making this study relatively novel in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients aged 16 to 70 years Clinical diagnosis of myofascial pain syndrome (MPS) Presence of active myofascial trigger points Pain duration ≥ 3 months Pain intensity ≥ 4 on the Visual Analog Scale (VAS) Trigger points located in accessible muscles No trigger point injection in the affected area within the past 3 months Ability and willingness to provide informed consent Willingness to comply with study procedures and follow-up visits Exclusion Criteria: Known allergy or hypersensitivity to lidocaine, sodium bicarbonate, or other amide-type local anesthetics Current use of anticoagulants or presence of bleeding disorders Local or systemic infection at or near the injection site History of fibromyalgia, cancer-related pain, or central pain syndromes Major psychiatric disorders (e.g., schizophrenia, severe depression) Recent trauma or surgery to the neck, shoulder, or back within the past 6 months Use of analgesics (e.g., NSAIDs, opioids) within 5 days prior to injection Severe systemic diseases (e.g., uncontrolled diabetes, liver failure, kidney failure, severe cardiovascular disease) \-
Where it's running
-
Faculty of Dentistry Cairo University
Cairo, Cairo Governorate, Egypt Recruiting
Study contacts
- Principal investigator: ola mohamed Abdelfath — cairo university oral and maxillofacial surgery department
- Study coordinator: ola mohamed Abdelfatah, bachelor
- Email: ola.abdelfatah@dentistry.cu.edu.eg
- Phone: +201122789240
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adding a greater occipital nerve block to trigger point injections for upper trapezius neck pain.
This will test whether adding an ultrasound-guided greater occipital nerve block to standard trigger point injections helps adults (18–65) with chronic upper trapezius trigger-point neck pain reduce pain and improve daily function.
-
Ischemic Release vs. Sustained Pressure Direct Myofascial Release for Upper Trapezius Trigger Points
In people with upper trapezius trigger points, this study tests whether ischemic release or sustained pressure direct myofascial release helps reduce pain and improve neck movement.
-
Dry needling and laser microcurrent therapy for neck muscle pain
This study tests whether dry needling and low-level laser microcurrent stimulation can reduce inflammation and oxidative stress while relieving pain and neck disability in adults with acute upper trapezius myofascial pain.
-
PRP, PRP with Betamethasone, or Betamethasone Injection for Upper Trapezius Myofascial Pain
Three injectable treatments are tested to see which best reduces pain and helps function for people with upper trapezius myofascial pain.
-
Magnesium sulfate added to lidocaine for trigger point injections in myofascial pain
This study will see if adding magnesium sulfate to lidocaine injections helps reduce pain and relax muscles in adults with myofascial pain dysfunction syndrome.
-
MET versus Neck Calliet exercises for neck pain in nurses
This project tests whether Muscle Energy Technique (MET) or Neck Calliet exercises better reduce neck pain and disability in young female nurses with trapezius trigger points.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.